MORGAN JESS S & CO INC
Filing Date
Global Rank
#5,176
/ 6,692
▲ 1
· as of Sep 2022
Top Industry
Biotechnology
14.7%
3Y Alpha vs SPY
-7.9%
Period ended 3 years ago
Filed Oct 21, 2022 · 3y
11 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+43.3%
SPY
+76.5%
Annualised alpha
-8.1%
Max drawdown
−15.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
16 positions · as of Sep 30, 2022 · Δ vs Jun 30, 2022Top Position
10.8%
+0.4 pts
Top 5
47.6%
+2.0 pts
Top 10
84.4%
+3.7 pts
HHI
798
Diversified+46
Portfolio Trend
11 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2022| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 43.6% | $21,991,555 |
| Unclassified | 20.6% | $10,371,856 |
| Technology | 18.7% | $9,428,121 |
| Consumer Defensive | 8.6% | $4,311,370 |
| Industrials | 6.4% | $3,215,571 |
| Financial Services | 2.2% | $1,095,890 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
13 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ORMP | Oramed Pharmaceuticals Inc. | +51,100 | 366,401 | $2,374,278 | |
| QQQ | Invesco Qqq Trust, Series 1 | +2,364 | 20,430 | $5,460,121 | |
| AVGO | Broadcom Inc. | +2,080 | 8,261 | $366,796 | |
| QQQX | Nuveen NASDAQ 100 Dynamic Overwrite Fund | +1,565 | 53,432 | $1,095,890 | |
| INTU | Intuit Inc. | +896 | 9,508 | $3,682,638 | |
| NVCR | NovoCure Ltd | +745 | 49,090 | $3,729,858 | |
| AAPL | Apple Inc. | +566 | 32,968 | $4,556,177 | |
| PEP | Pepsico Inc | +565 | 26,408 | $4,311,370 | |
| JNJ | Johnson & Johnson | +415 | 25,327 | $4,137,418 | |
| HON | Honeywell International Inc | +250 | 19,483 | $3,215,571 | |
| MSFT | Microsoft Corp | +150 | 3,212 | $748,074 | |
| UNH | Unitedhealth Group Inc | +102 | 9,416 | $4,755,456 | |
| TMO | Thermo Fisher Scientific Inc. | +89 | 6,850 | $3,474,251 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
16 positions ·
$50,414,363 total
· as of Sep 30, 2022
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| QQQ |
Invesco Qqq Trust, Series 1
|
Added | 20,430 | $5,460,121 | 10.83% | |
| DBC |
Invesco DB Commodity Index Tracking Fund
|
Reduced | 205,426 | $4,911,735 | 9.74% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 9,416 | $4,755,456 | 9.43% | |
| AAPL |
Apple Inc.
Technology
|
Added | 32,968 | $4,556,177 | 9.04% | |
| PEP |
Pepsico Inc
Consumer Defensive
|
Added | 26,408 | $4,311,370 | 8.55% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Added | 25,327 | $4,137,418 | 8.21% | |
| NVCR |
NovoCure Ltd
Healthcare
|
Added | 49,090 | $3,729,858 | 7.40% | |
| INTU |
Intuit Inc.
Technology
|
Added | 9,508 | $3,682,638 | 7.30% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 78,895 | $3,520,294 | 6.98% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Added | 6,850 | $3,474,251 | 6.89% | |
| HON |
Honeywell International Inc
Industrials
|
Added | 19,483 | $3,215,571 | 6.38% | |
| ORMP |
Oramed Pharmaceuticals Inc.
Healthcare
|
Added | 366,401 | $2,374,278 | 4.71% | |
| QQQX |
Nuveen NASDAQ 100 Dynamic Overwrite Fund
Financial Services
|
Added | 53,432 | $1,095,890 | 2.17% | |
| MSFT |
Microsoft Corp
Technology
|
Added | 3,212 | $748,074 | 1.48% | |
| AVGO |
Broadcom Inc.
Technology
|
Added | 8,261 | $366,796 | 0.73% | |
| NVDA |
Nvidia Corp
Technology
|
Held | 6,132 | $74,436 | 0.15% |